Jaime Tome-Amat

Prof. Jaime Tome-Amat

Technical University of Madrid, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Plant Physiology and Biochemistry
Verified
Journal Article
Open access
KMKhawla Missaoui
Khawla Missaoui
ZGZulema Gonzalez-Klein
Zulema Gonzalez-Klein
DPDiego Pazos-Castro
Diego Pazos-Castro
GHGuadalupe Hernandez-Ramirez
Guadalupe Hernandez-Ramirez
MGMaría Garrido-Arandia
María Garrido-Arandia
JTJaime Tome-Amat
Jaime Tome-Amat
Plant non-specific lipid transfer proteins (nsLTPs) are usually defined as small, basic proteins, with a wide distribution in all orders of higher plants. Structurally, nsLTPs contain a conserved motif of eight cysteines, linked by four disulphide bonds, and a hydrophobic cavity in which the ligand is housed. This structure confers stability and enhances the ability to bind and transport a variety of hydrophobic molecules. Their highly conserved structural resemblance but low sequence identity reflects the wide variety of ligands they can carry, as well as the broad biological functions to which they are linked to, such as membrane stabilization, cell wall organization and signal transduction. In addition, they have also been described as essential in resistance to biotic and abiotic stresses, plant growth and development, seed development, and germination. Hence, there is growing interest in this family of proteins for their critical roles in plant development and for the many unresolved questions that need to be clarified, regarding their subcellular localization, transfer capacity, expression profile, biological function, and evolution.

7 October 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
GRGuadalupe Hernández Ramírez
Guadalupe Hernández Ramírez
DBDomingo Barber
Domingo Barber
JTJaime Tome-Amat
Jaime Tome-Amat
MGMaría Garrido-Arandia
María Garrido-Arandia
Araceli Díaz-PeralesAraceli Díaz-Perales
Araceli Díaz-Perales
Alternaria alternata is a saprophytic mold whose spores are disseminated in warm dry air, the typical weather of the Mediterranean climate region (from 30° to 45°), with a peak during the late summer and early autumn. Alternaria spores are known to be biological contaminants and a potent source of aeroallergens. One consequence of human exposure to Alternaria is an increased risk of developing asthma, with Alt a 1 as its main elicitor and a marker of primary sensitization. Although the action mechanism needs further investigation, a key role of the epithelium in cytokine production, TLR-activated alveolar macrophages and innate lymphoid cells in the adaptive response was demonstrated. Furthermore, sensitization to A. alternata seems to be a trigger for the development of co-sensitization to other allergen sources and may act as an exacerbator of symptoms and an elicitor of food allergies. The prevalence of A. alternata allergy is increasing and has led to expanding research on the role of this fungal species in the induction of IgE-mediated respiratory diseases. Indeed, recent research has allowed new perspectives to be considered in the assessment of exposure and diagnosis of fungi-induced allergies, although more studies are needed for the standardization of immunotherapy formulations.

19 January 2024 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
APAllyssa Phelps
Allyssa Phelps
DPDiego Pazos-Castro
Diego Pazos-Castro
FUFrancesca Urselli
Francesca Urselli
EGEmily Grydziuszko
Emily Grydziuszko
OMOlivia Mann-Delany
Olivia Mann-Delany
JKJoshua F. E. Koenig
Joshua F. E. Koenig

19 April 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
PDF file
ENEmilio Nuñez‐Borque
Emilio Nuñez‐Borque
SFSergio Fernandez‐Bravo
Sergio Fernandez‐Bravo
PRPablo Rodríguez Del Río
Pablo Rodríguez Del Río
EAEbrahim Mohammed Alwashali
Ebrahim Mohammed Alwashali
DLDavid Lopez‐Dominguez
David Lopez‐Dominguez
Vanesa EstebanVanesa Esteban
Vanesa Esteban
Background: Anaphylaxis is the most severe manifestation of allergic disorders. The poor knowledge of its molecular mechanisms often leads to under‐diagnosis. MicroRNAs (miRNA) regulate physiologic and pathologic processes, and they have been postulated as promising diagnostic markers. The main objectives of this study were to characterize the human miRNA profile during anaphylaxis and to assess their capacity as diagnostic markers and determine their participation in the molecular mechanisms of this event.Methods: The miRNA serum profiles from the acute and baseline phase of 5 oral food‐challenged anaphylactic children (<18 years old) were obtained by next‐generation sequencing (NGS). From the panel of statistically significant miRNAs obtained, several candidates were selected and analyzed in 19 anaphylactic children by qPCR. We performed system biology analysis (SBA) on their target genes to identify main functions and canonical pathways. A functional in vitro assay was carried out incubating endothelial cells (ECs) in anaphylactic conditions.Results: The NGS identified 389 miRNAs among which 41 were significantly different between acute and baseline samples. The high levels of miR‐21‐3p (fold change = 2.28, P = .006) and miR‐487b‐3p (fold change = 1.04, P = .039) observed by NGS in acute serum samples were confirmed in a larger group of 19 patients. The SBA revealed molecular pathways related to the inflammation and immune system regulation. miR‐21‐3p increased intracellularly and in acute phase serum after EC stimulation.Conclusions: These findings provide, for the first time, some insights into the anaphylactic miRNA serum profile in children and point to miR‐21‐3p and miR‐487b‐3p as candidate biomarkers. Furthermore, the SBA revealed a possible implication of these molecules in the underlying molecular mechanisms. Moreover, ECs increased miR‐21‐3p intracellularly and released it to the environment in response to anaphylaxis.

1 February 2020 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
NMNerea Mendez-Barbero
Nerea Mendez-Barbero
AYAlma Yuste-Montalvo
Alma Yuste-Montalvo
ENEmilio Nuñez-Borque
Emilio Nuñez-Borque
BJBettina M. Jensen
Bettina M. Jensen
CGCarmen Gutiérrez-Muñoz
Carmen Gutiérrez-Muñoz
Vanesa EstebanVanesa Esteban
Vanesa Esteban
Anaphylaxis includes mast cell (MC) activation, but less is known about downstream mechanisms (ie, vascular permeability controlled by endothelial cells [ECs]). The TNF-like weak inducer of apoptosis (TWEAK) and its sole receptor, fibroblast growth factor-inducible molecule 14 (Fn14), belong to the TNF superfamily and are involved in proinflammatory responses. We sought to investigate the role of TWEAK/Fn14 axis in anaphylaxis. In vivo vascular permeability and mouse models of passive systemic anaphylaxis (PSA) and active systemic anaphylaxis were applied to wild-type (WT), TWEAK- and Fn14-deficient mice (TWEAK-/- and Fn14-/-, respectively). Primary bone marrow-derived mast cells (BMMCs) and ECs from WT and Fn14-/- or TWEAK-/- mice were studied. The TWEAK/Fn14 axis was also investigated in human samples. Mice with PSA and active systemic anaphylaxis had increased Fn14 and TWEAK expression in lung tissues and increased serum soluble TWEAK concentrations. TWEAK and Fn14 deficiencies prevent PSA-related symptoms, resulting in resistance to decreased body temperature, less severe reactions, and maintained physical activity. Numbers of MCs after PSA are similar between genotypes in different tissue regions, such as ear skin and the trachea, tongue, peritoneum, lungs, and bone marrow. Moreover, in vitro studies revealed no differences in degranulation or mediator release between WT and Fn14-/- BMMCs after IgE-FcεRI stimulation. In vivo and in vitro histamine and platelet-activating factor administration increases Fn14 receptor expression in lungs and ECs. Moreover, Fn14 deficiency in ECs maintained in vitro impermeability when stimulated by mediators or activated BMMCs but not by TWEAK-/- BMMCs, indicating that Fn14 is crucial for endothelial barrier function. TWEAK/Fn14 deletion or TWEAK-blocking antibody prevented histamine/platelet-activating factor-induced vascular subcutaneous permeability. Circulating soluble TWEAK levels were increased in patients with anaphylaxis, and plasma from those patients increased Fn14 expression in ECs. The TWEAK/Fn14 axis participates in anaphylactic reactions. Inhibition of TWEAK/Fn14 interaction could be efficacious in anaphylaxis therapy.

19 June 2012 in Protein Engineering, Design and Selection
Verified
Journal Article
Open access
PDF file
NCNelson Carreras-Sangrà
Nelson Carreras-Sangrà
JTJaime Tome-Amat
Jaime Tome-Amat
LGLucia Garcia-Ortega
Lucia Garcia-Ortega
CBCarl A. Batt
Carl A. Batt
MOMercedes Oñaderra
Mercedes Oñaderra
JLJavier Lacadena
Javier Lacadena
A single-chain fusion protein that directed the cytolytic activity of α-sarcin to A33 tumor antigen expressing cells was constructed and shown to effectively kill targeted cells. Glycoprotein A33 (GPA33) is a well-known colon cancer marker and a humanized antibody against it was used to target the α-sarcin. The fungal ribotoxin α-sarcin is one of the most potent and specific toxins known. It is small, protease resistant, thermostable and highly efficient towards the inactivation of ribosomes. This work describes the production and characterization of an immunotoxin resulting from fusing the single-chain variable fragment (scFv) of the monoclonal antibody that targets GPA33 to fungal α-sarcin. This chimeric protein (scFvA33αsarcin), produced in Pichia pastoris and purified in high yield was proven to be properly folded, active, specific and stable. It showed high specific toxicity against GPA33-positive tumoral cell lines providing scientific evidence to sustain that scFvA33αsarcin is a good immunotherapeutic candidate against GPA33-positive colon carcinomas.